ClinicalTrials.gov
ClinicalTrials.gov Menu

Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis (ALPS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01887600
Recruitment Status : Completed
First Posted : June 27, 2013
Last Update Posted : October 23, 2018
Sponsor:
Collaborator:
FibroGen
Information provided by (Responsible Party):
Astellas Pharma Inc ( Astellas Pharma Europe B.V. )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 1, 2017
  Actual Study Completion Date : November 1, 2017
  Certification/Extension First Submitted : October 18, 2018